Literature DB >> 3285125

Clinical features and management of lithium poisoning.

A Amdisen1.   

Abstract

Lithium salts, in particular the carbonate and citrate, were formerly in widespread use, forming part of alkaline salt mixtures which were used for treatment of the many disorders belonging to the uric acid diathesis. Among these disorders were mania, depression, acute mania, acute melancholia and periodic depression. Satisfactory prophylactic effects on periodic depression were directly claimed. Daily doses of 3 to 26 mmol of lithium were recommended as standards. Only slight or moderate symptoms of poisoning were reported in a very few cases during the period in question (1860 to 1930), when the popularity of these lithium-containing prophylactic drugs with a favourable therapeutic index was at its peak. Lithium intoxication was not a serious clinical problem until 1949 when Cade introduced his fortuitously effective, but nevertheless high, dosage regimen which was continued until signs of recovery from mania appeared. For the maintenance dose, Cade in principle recommended, but seldom adhered to, 17 mmol/day. Chronic lithium intoxication starts insidiously with silent affliction of the kidneys followed by 'prodromal' symptoms, and when moderate severity has been reached, an accelerating renal vicious circle with decreasing kidney function is imminent. After this point the chronic intoxication resembles acute intoxication. Active detoxification at this, or an earlier stage, leaves the patient with a good chance of recovery. At a later stage, with the occurrence of oliguria, semi-coma or coma, and latent convulsive movement, recovery is less certain. There is no specific antidote for the toxic effects of lithium. Haemodialysis is the most effective treatment for acute lithium poisoning. For patients with impaired, or potentially impaired renal function, peritoneal dialysis may be an alternative, but less effective, treatment. Forced diuresis demands unimpaired renal function, and is little more effective than withdrawal of treatment, supplemented with correction of water and electrolyte balance. Sodium overloading is not recommended. Patients on lithium prophylaxis are treated on an outpatient basis. Prevention of intoxication depends on cooperation between patient and clinician, and possibly on the use of smaller, low risk dosages in most patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3285125     DOI: 10.1007/bf03259929

Source DB:  PubMed          Journal:  Med Toxicol Adverse Drug Exp        ISSN: 0113-5244


  42 in total

1.  The treatment of manic psychoses by the administration of lithium salts.

Authors:  M SCHOU; N JUEL-NIELSEN; E STROMGREN; H VOLDBY
Journal:  J Neurol Neurosurg Psychiatry       Date:  1954-11       Impact factor: 10.154

2.  Lithium salts in the treatment of psychotic excitement.

Authors:  J F J CADE
Journal:  Med J Aust       Date:  1949-09-03       Impact factor: 7.738

3.  Pearson's correlation coefficient, p-value, and lithium therapy.

Authors:  A Amdisen
Journal:  Biol Psychiatry       Date:  1987-07       Impact factor: 13.382

4.  Spontaneous toxicokinetics of lithium during a therapeutic overdose with renal failure.

Authors:  C Bismuth; F J Baud; F Buneaux; X Du Fretay
Journal:  J Toxicol Clin Toxicol       Date:  1986

5.  Serum lithium estimations.

Authors:  A Amdisen
Journal:  Br Med J       Date:  1973-04-28

6.  Acute lithium neurotoxicity.

Authors:  R S el-Mallakh
Journal:  Psychiatr Dev       Date:  1986

7.  Renal histopathology in various forms of acute anuria in man.

Authors:  S Olsen
Journal:  Kidney Int Suppl       Date:  1976-10       Impact factor: 10.545

Review 8.  Renal toxicity of lithium.

Authors:  H E Hansen
Journal:  Drugs       Date:  1981-12       Impact factor: 9.546

9.  Minimum plasma lithium levels required for effective prophylaxis in DSM III bipolar disorder: a prospective study.

Authors:  M Maj; F Starace; G Nolfe; D Kemali
Journal:  Pharmacopsychiatry       Date:  1986-11       Impact factor: 5.788

10.  Decreasing lithium dosage reduces morbidity and side-effects during prophylaxis.

Authors:  A Coppen; M Abou-Saleh; P Milln; J Bailey; K Wood
Journal:  J Affect Disord       Date:  1983-11       Impact factor: 4.839

View more
  9 in total

Review 1.  Therapeutic drug monitoring of psychotropic medications.

Authors:  P B Mitchell
Journal:  Br J Clin Pharmacol       Date:  2000-04       Impact factor: 4.335

2.  A 4-year study of lithium intoxication reported to the Czech Toxicological Information Centre.

Authors:  Martina Krenová; Daniela Pelclová
Journal:  Pharm World Sci       Date:  2006-11-17

Review 3.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

Review 4.  Extracorporeal Treatment for Lithium Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup.

Authors:  Brian S Decker; David S Goldfarb; Paul I Dargan; Marjorie Friesen; Sophie Gosselin; Robert S Hoffman; Valéry Lavergne; Thomas D Nolin; Marc Ghannoum
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-12       Impact factor: 8.237

Review 5.  Therapeutic drug monitoring in drug overdose.

Authors:  A H Dawson; I M Whyte
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

6.  Delirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: a case report.

Authors:  Cengiz Tuglu; Esin Erdogan; Ercan Abay
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

Review 7.  Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety.

Authors:  Etienne Marc Grandjean; Jean-Michel Aubry
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 8.  Lithium intoxication: a coordinated treatment approach.

Authors:  S L Minden; E L Bassuk; S P Nadler
Journal:  J Gen Intern Med       Date:  1993-01       Impact factor: 5.128

Review 9.  Use of psychotropic medications in treating mood disorders during lactation : practical recommendations.

Authors:  Malin Eberhard-Gran; Anne Eskild; Stein Opjordsmoen
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.